This site is intended for health professionals only

Home / Clinical / Pharmacists meet with NHS to discuss HIV prevention drug access

Pharmacists meet with NHS to discuss HIV prevention drug access

People meeting in a board room

By Rebecca Jenkins

21 Jun 2021

Groups in support of community pharmacies offering the HIV prevention drug pre-exposure prophylaxis (PrEP), including representatives from the sector, have met with NHS officials to discuss the proposals, an MP has said.   

MP for Carshalton and Wallington Elliot Colburn met late last week (June 11) with NHSE&I, HIV/AIDS charities and representatives from the pharmacy sector to talk about community pharmacies delivering PrEP. 

‘It was a very positive meeting and I’m delighted that NHSE&I are receptive to the idea,’ he told the Pharmacist

‘The possibility of pilots was discussed, but it is clear these are very early days indeed, so I will be having follow up discussions with them once they have had time to explore it in greater detail.’ 

The meeting comes after Mr Colburn and supporters wrote to NHS chief Sir Simon Stevens in April arguing for PrEP to be accessible in the community beyond sexual health clinics. The letter noted that currently most people accessing PrEP where white and male and did not reflect all the communities at risk of HIV. 

‘Community pharmacy is a massively untapped resource as a whole in the health and social care space in the UK, and one area specifically I believe they can have an impact is in sexual health,’ Mr Colburn told the Pharmacist

‘I hope this is the beginning of great news. Expanding the availability of PrEP to pharmacy can only be a good thing to reach the ambitions of the HIV Action Plan, but also to demonstrate just how much more of a role pharmacy can and should be permitted to play in shaping the health of our country.’ 

News of the discussions comes as an English study published in Lancet HIV showed the annual number of HIV infections among men who have sex with men (MSM) fell dramatically from 2,770 in 2013 to 854 in 2018. 

Using novel statistical modelling of an array of English HIV surveillance information, the University of Cambridge researchers found the decline was consistent across all age groups but was particularly marked in MSM aged 25-34 years old, and slowest in those aged 45 years and older. 

They noted the decline began before the widespread introduction of PrEP in 2016, highlighting the impact of the enhanced testing and earlier treatment strategy that was scaled up between 2011 and 2015. 

Extrapolating the figures, the researchers concluded a 40% probability that England would reach the UN HIV elimination target by 2030, but recommended targeting prevention measures at MSM aged 45 years and older to boost these efforts. 


Want news like this straight to your inbox?


Latest News

cancer alcohol
Over 4% of new cancers caused by alcohol, study suggests
Both heavy and moderate alcohol consumption among adults globally is now thought to have caused...
flu programme
Record-sized flu programme to target 35 million people for vaccinations
An expanded national flu vaccination programme this winter will target 35 million people across the...
Girl holding her head
Benefits of migraine medication can continue for three years post-use in children, study finds
Children with headaches whose migraines get better while taking preventive medication can stop the pills...